Name | Value |
---|---|
Revenues | 1,847.0K |
Cost of Revenue | 1,469.0K |
Gross Profit | 378.0K |
Operating Expense | 4,505.0K |
Operating I/L | -4,127.0K |
Other Income/Expense | -235.0K |
Interest Income | 0.0K |
Pretax | -4,362.0K |
Income Tax Expense | 0.0K |
Net Income/Loss | -4,362.0K |
Avinger, Inc. is a medical device company specializing in image-guided and catheter-based systems for treating peripheral arterial disease (PAD). Its lumivascular platform integrates optical coherence tomography with interventional catheters, providing real-time intravascular imaging during PAD procedures. The company's products include Lightbox imaging consoles, Ocelot catheters for penetrating arterial blockages, Pantheris atherectomy device for plaque removal, and CTO-crossing catheters Wildcat and Kittycat 2. Avinger also develops IMAGE-BTK for below-the-knee PAD lesions. Its customers are interventional cardiologists, vascular surgeons, and interventional radiologists.